1.
An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice
by Shin, Na-Ri
Gut, 2014-05, Vol.63 (5), p.727-735
2.
Type 1 diabetes
by Atkinson, Mark A, Prof
The Lancet (British edition), 2014, Vol.383 (9911), p.69-82
3.
Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial
by Dungan, Kathleen M, Dr
The Lancet (British edition), 2014, Vol.384 (9951), p.1349-1357
4.
2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiori...
by Gallwitz, Baptist, Prof
The Lancet (British edition), 2012, Vol.380 (9840), p.475-483
5.
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
by Currie, C. J
Diabetologia, 2009-07-02, Vol.52 (9), p.1766-1777
6.
Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study
by Buse, John B, Prof
The Lancet (British edition), 2013, Vol.381 (9861), p.117-124
7.
Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial
by Lavalle-González, F. J
Diabetologia, 2013-09-13, Vol.56 (12), p.2582-2592
8.
Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study
by Drucker, Daniel J, Dr
The Lancet (British edition), 2008, Vol.372 (9645), p.1240-1250
9.
Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, dou...
by Cefalu, William T, Prof
The Lancet (British edition), 2013, Vol.382 (9896), p.941-950
10.
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
by Drucker, Daniel J
The Lancet (British edition), 2006, Vol.368 (9548), p.1696-1705
11.
Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a...
by Heller, Simon, Prof
The Lancet (British edition), 2012, Vol.379 (9825), p.1489-1497
12.
Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial
by Bergenstal, Richard M, Dr
The Lancet (British edition), 2010, Vol.376 (9739), p.431-439
13.
Effect of intensive insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial
by Weng, Jianping, Prof
The Lancet (British edition), 2008, Vol.371 (9626), p.1753-1760
14.
Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial
by Sherry, Nicole, Dr
The Lancet (British edition), 2011, Vol.378 (9790), p.487-497
15.
DURATION-5: Exenatide Once Weekly Resulted in Greater Improvements in Glycemic Control Compared with Exenatide Twice Daily in Patients with Type 2 Diabetes
by Blevins, Thomas
The journal of clinical endocrinology and metabolism, 2011-05, Vol.96 (5), p.1301-1310
16.
GLP-1 Neurons in the Nucleus of the Solitary Tract Project Directly to the Ventral Tegmental Area and Nucleus Accumbens to Control for Food Intake
by Alhadeff, Amber L
Endocrinology (Philadelphia), 2012-02, Vol.153 (2), p.647-658
17.
Management of type 2 diabetes: new and future developments in treatment
by Tahrani, Abd A, MD
The Lancet (British edition), 2011, Vol.378 (9786), p.182-197
18.
The Effect of Lifestyle Intervention and Metformin on Preventing or Delaying Diabetes Among Women With and Without Gestational Diabetes: The Diabetes Prevention Program Outcomes St...
by Aroda, V. R
The journal of clinical endocrinology and metabolism, 2015-04, Vol.100 (4), p.1646-1653
19.
Diabetes Technology—Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline
by Peters, Anne L
The journal of clinical endocrinology and metabolism, 2016-11, Vol.101 (11), p.3922-3937
20.
Comparative Efficacy and Safety of OADs in Management of GDM: Network Meta-analysis of Randomized Controlled Trials
by Jiang, Yun-Fa
The journal of clinical endocrinology and metabolism, 2015-05, Vol.100 (5), p.2071-2080
